International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum β-Lactamase Production in Nosocomial Infections

Annals of Internal Medicine

Volumn 140, Issue 1, 2004, Pages 26-32

  Paterson, David L ^b   Ko, Wen Chien ^b   Von Gottberg, Anne ^b   Mohapatra, Sunlta ^b   Casellas, Jose Maria ^b   Goossens, Herman ^b   Mulazimoglu, Lutfiye ^b   Trenholme, Gordon ^b   Klugman, Kelth P ^b   Bonomo, Robert A ^b   Rice, Louis B ^b   Wagener, Marilyn M ^b   McCormack, Joseph G ^b   Yu, Victor L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME;

ADOLESCENT; ADULT; AFRICA; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARGENTINA; ARTICLE; AUSTRALIA; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BELGIUM; CONFIDENCE INTERVAL; ENZYME SYNTHESIS; EPIDEMIOLOGICAL DATA; FEMALE; GENOTYPE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; JAPAN; KLEBSIELLA PNEUMONIAE; LABORATORY; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN; TURKEY (REPUBLIC); UNITED STATES;

EID: 9144232354     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-140-1-200401060-00008     Document Type: Article

References (29)

1. Jacoby GA. Genetics of extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis. 1994;13 Suppl 1:S2-11. [PMID: 7821301]
2. Jacoby GA. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams. Infect Dis Clin North Am. 1997;11:875-87. [PMID: 9421705]
3. Tenover FC, Mohammad JM, Gorton T, Dembek ZF. Detection and reporting of extended-spectrum beta-lactamase (ESBL) producing organisms in Connecticut. Clin Infect Dis. 1998;27:1064.
4. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med. 1993,119:353-8. [PMID: 8135915]
5. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280:1233-7. [PMID: 9786372]
6. Korvick JA, Bryan CS, Farber B, Beam TR Jr, Schenfeld L, Muder RR, et al. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother. 1992;36:2639-44. [PMID: 1482131]
7. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991;115:585-90. [PMID: 1892329]
8. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents. 1999;11:7-12. [PMID: 10075272]
9. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619-36. [PMID: 1959406]
10. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-40. [PMID: 2841893]
11. Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis. 2000;30:473-8. [PMID: 10722430]
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Ninth Informational Supplement. Wayne, PA: National Committee for Clinical Laboratory Standards; 1999.
13. Casewell MW, Phillips I. Aspects of the plasmid-mediated antibiotic resistance and epidemiology of Klebsiella species. Am J Med. 1981;70:459-62. [PMID: 7468627]
14. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Setratia marcescens. Infection. 1983;11:315-7. [PMID: 6321357]
15. Payne DJ, Marriott MS, Amyes SG. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2. J Med Microbiol. 1990;32:131-4. [PMID: 2192063]
16. Casellas JM, Goldberg M. Incidence of strains producing extended spectrum beta-lactamases in Argentina. Infection. 1989;17:434-6. [PMID: 2613338]
17. Monnet DL, Biddle JW, Edwards JR, Culver DH, Tolson JS, Martone WJ, et al. Evidence of interhospital transmission of extended-spectrum beta-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. The National Nosocomial Infections Surveillance System. Infect Control Hosp Epidemiol. 1997;18:492-8. [PMID: 9247832]
18. Laboratory capacity to detect antimicrobial resistance, 1998. MMWR Morb Mortal Wkly Rep. 2000;48:1167-71.
19. Rice LB, Willey SH, Papanicolaou GA, Medeiros AA, Eliopoulos GM, Moellering RC Jr, et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother. 1990;34:2193-9. [PMID: 2073110]
20. Naumovski L, Quinn JP, Miyashiro D, Patel M, Bush K, Singer SB, et al. Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob Agents Chemother. 1992;36:1991-6. [PMID: 1416892]
21. Coulter C, Faoagali JC, Doige S, Bodman J, George N. Hand culture surveillance to investigate transmission of epidemic extended-spectrum beta-lactamase producing Klebsiella pneumoniae in a major intensive care unit [Abstract]. Austr N Z J Med. 1995;25:572.
22. Pena C, Pujol M, Ricart A, Ardanuy C, Ayats J, et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect. 1997;35:9-16. [PMID: 9032631]
23. Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resisrant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis. 1996;23:118-24. [PMID: 8816140]
24. Piroth L, Aube H, Doise JM, Vincent-Martin M. Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: are beta-lactamase inhibitors of therapeutic value? Clin Infect Dis. 1998;27:76-80. [PMID: 9675456]
25. Amyes SG, Miles RS. Extended-spectrum beta-lactamases: the role of inhibitors in therapy. J Antimicrob Chemother. 1998;42:415-7. [PMID: 9818738]
26. Paterson DL, Yu VL. Extended-spectrum beta-lactamases: a call for improved detection and control [Editorial]. Clin Infect Dis. 1999;29:1419-22. [PMID: 10585789]
27. Gaillot O, Mauejouls C, Abachin E, Lecuru F, Arlet G, Simonet M, et al. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol. 1998;36:1357-60. [PMID: 9574705]
28. Eisen D, Russell EG, Tymms M, Roper EJ, Grayson ML, Turnidge J. Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniae. J Clin Microbiol. 1995;33:713-7. [PMID: 7751382]
29. Hobson RP, MacKenzie FM, Gould IM. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. J Hosp Infect. 1996;33:249-62. [PMID: 8864938]